The estimated Net Worth of Elisha W Finney is at least $11.3 Milione dollars as of 16 May 2024. Ms. Finney owns over 300 units of ICU Medical stock worth over $362,824 and over the last 21 years she sold ICUI stock worth over $10,664,505. In addition, she makes $267,014 as Independent Director at ICU Medical.
Elisha has made over 120 trades of the ICU Medical stock since 2003, according to the Form 4 filled with the SEC. Most recently she sold 300 units of ICUI stock worth $31,485 on 16 May 2024.
The largest trade she's ever made was exercising 50,000 units of ICU Medical stock on 1 November 2004 worth over $697,500. On average, Elisha trades about 3,811 units every 32 days since 2003. As of 16 May 2024 she still owns at least 2,129 units of ICU Medical stock.
You can see the complete history of Ms. Finney stock trades at the bottom of the page.
Elisha W. Finney serves as Independent Director of the Company. Ms Finney was named Vice President, Finance and CFO of Varian Medical Systems in April 1999. In January 2005, she was promoted to Senior Vice President and given additional management responsibility for the Corporate Information Systems group. She was named Executive Vice President in February 2012. Varian Medical Systems is a leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Ms. Finney managed a worldwide staff of 400. Her management responsibilities included corporate accounting; corporate communications and investor relations; internal financial and compliance audit; risk management; tax and treasury, and corporate information systems. Ms. Finney joined Varian as risk manager in 1988 and has assumed a wide variety of finance functions over her last 27 years with the company. Prior to joining Varian, Ms. Finney was with the Fox Group in Foster City, CA, and Beatrice Foods, a major food processing company, in Chicago, IL. Ms. Finney has served on the boards of: iRobot Corporation, a robotics technology company, since January 2017; NanoString Technologies, a company that specializes in development of cancer diagnostics tools, since May 2017; Mettler Toledo, a multinational manufacturer of scales and analytical instruments, since November 2017; and Cutera, Inc. a global provider of laser and other energy-based aesthetic systems, from November 2017 to May 2019. Ms. Finney previously served on the boards of directors of: Laserscope from August 2005 until July 2006 when Laserscope was sold to American Medical Systems; Thoratec, a developer, manufacturer and marketer of proprietary medical devices for mechanical circulatory support from July 2007 to May 2013; and Altera Corporation, a manufacturer of programmable logic devices from September 2011 until December 2015, when Altera was sold to Intel.
As the Independent Director of ICU Medical, the total compensation of Elisha Finney at ICU Medical is $267,014. There are 9 executives at ICU Medical getting paid more, with Vivek Jain having the highest compensation of $2,825,280.
Elisha Finney is 58, she's been the Independent Director of ICU Medical since 2016. There are 3 older and 10 younger executives at ICU Medical. The oldest executive at ICU Medical, Inc. is Robert Swinney, 74, who is the Independent Director.
Elisha's mailing address filed with the SEC is 951 CALLE AMANECER, , SAN CLEMENTE, CA, 92763.
Over the last 22 years, insiders at ICU Medical have traded over $1,321,280,834 worth of ICU Medical stock and bought 67,835 units worth $8,096,830 . The most active insiders traders include Incc.P. Pharmaceuticals Int..., George A Lopez e Vivek Jain. On average, ICU Medical executives and independent directors trade stock every 9 days with the average trade being worth of $2,984,225. The most recent stock trade was executed by Vivek Jain on 3 September 2024, trading 12,000 units of ICUI stock currently worth $1,065,120.
icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.
ICU Medical executives and other stock owners filed with the SEC include: